20599 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Sub-classes:PH-DEPENDENT ANTI-CD3 ANTIBODIES AND METHODS RELATING THERETO
#2ACTIVATED STEM CELLS AND SYSTEMIC TREATMENT METHODS FOR INFECTED WOUNDS
#3UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
#4TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS
#5COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#6ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF
#7CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELL THAT TARGETS EGFR
#8COMPOSITIONS AND METHODS FOR DELIVERY OF TRUNCATED MIDKINE PROTEINS
#9CHOLESTEROL-MODIFIED HYALURONIC ACIDS
#10HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF
#11COMPOSITIONS FOR TREATING COLITIS AND/OR PREVENTING COLON CANCER
#12METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
#13COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#14Cell
#15TM4SF1 CAR CELLS AND METHODS OF USE THEREOF
#16COMPOSITION FOR REGULATING SPLICING OF POLYBROMO 1 GENE COMPRISING SPLICING-SWITCH OLIGONUCLEOTIDE AS EFFECTIVE COMPONENT
#17COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID
#18COMPOSITIONS OF LIPID NANOPARTICLES FOR PLASMID DNA DELIVERY TO THE LIVER AND METHODS FOR PREPARING THE SAME
#19FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES
#20ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF
#21METHOD OF ADMINISTRATION AND TREATMENT
#22METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA
#23PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN
#24IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF
#25ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF
#26ANTIBODIES BINDING TO HLA-A2/WT1
#27POLYPEPTIDE, PRODUCT INCLUDING POLYPEPTIDE FOR INHIBITING FUSOBACTERIUM NUCLEATUM, OR DRUG FOR PREVENTING COLORECTAL CANCER
#28GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY
#29TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#30DLL3 BINDING MOLECULES AND USES THEREOF
#31Prevention and treatment of depressive disorders and conditions promoted by protease containing plasma extracellular vesicles (PCpEV)
#32Antibody Targeting Axl Protein and Antigen Binding Fragment Thereof, and Preparation Method Therefor and Application Thereof
#33TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#34HER2 VACCINE COMPOSITION
#35METHODS OF TREATING CANCERS OVEREXPRESSING CARM1 WITH EZH2 INHIBITORS AND A PARP INHIBITOR
#36MHC-INDEPENDENT TCRs AND METHODS OF MAKING AND USING SAME
#37Linker Polypeptides
#38ENGINEERED ANTIBODY COMPOUNDS AND CONJUGATES THEREOF
#39TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN
#40COMPOSITIONS AND METHODS FOR WOUND TREATMENT
#41FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES
#42Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
#43COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#44Composition for inducing proliferation or accumulation of regulatory T cells
#45ANTI-HER3 ANTIBODY, ANTIBODY DRUG CONJUGATE CONTAINING THE SAME, AND USE THEREOF
#46CELL COMPOSITIONS FOR TISSUE REGENERATION
#47THERAPEUTIC STRATEGY FOR NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#48SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE
#49USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME
#50Production of Activated TDP-Deoxysugars in Recombinant Microorganisms
#51TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS
#52METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
#53Method of administration and treatment
#54TUMOR CELL VACCINES
#55METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA
#56EXOSOMES CONTAINING MIRNAS TARGETING HER2 SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS
#57Mutant Bordetella Strains and Methods of Use
#58TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES
#59CELL
#60FOLLICULAR FLUID METHOD
#61DETERMINING CANCER RESPONSIVENESS TO TREATMENT
#62METHODS FOR INDUCING CELL DIVISION OF POSTMITOTIC CELLS
#63Oxygen Reduction Disposable Kits, Devices and Methods of Use Thereof
#64Nucleoporins as drug targets for anti-proliferative therapeutics
#65BCMA BINDING MOLECULES AND METHODS OF USE THEREOF
#66Method for Treating Cancerous and Pre-Cancerous Skin
#67ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE
#68COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT
#69Method for treating cancerous and pre-cancerous skin
#70composition and use thereof for improving anxiety caused by antibiotics
#71COMPOSITIONS AND METHODS OF USING INDUCIBLE SIGNALING FOR TUNABLE DYANMICS IN MICROBIAL COMMUNITIES
#72BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOF
#73Toxicity Management for Anti-Tumor Activity of CARs
#74METHOD AND COMPOSITION FOR INDUCING HUMAN PLURIPOTENT STEM CELLS
#75Compositions and methods for wound treatment
#76Antibodies binding to HLA-A2/WT1
#77AEROSOLIZED COMPOSITIONS COMPRISING MITOCHONDRIA AND METHODS OF USE THEREOF
#78ANTI-PD-L1 SINGLE-DOMAIN ANTIBODIES
#79ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
#80Engineered Peptide and Peptide Mimetic Compositions and Methods
#81METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#82HUMANIZED ANTIBODIES AGAINST PD-L1
#83THERAPEUTIC MITOCHONDRIAL PEPTIDES
#84METHOD FOR ESTABLISHING FINGERPRINT OF TRADITIONAL CHINESE MEDICINE COMPOUND OR ITS PREPARATION WITH IMPROVING COGNITION
#85MAGE-A4 T CELL RECEPTORS AND METHODS OF USE THEREOF
#86METHOD OF SYNTHESIS OF COMPOUND FOR DUAL INHIBITION OF JAK2 AND BET
#87Oxygen reduction disposable kits, devices and methods of use thereof
#88A METHOD OF IN VITRO CHONDROCYTE AND CARTILAGE CULTURE TO OBTAIN MATERIAL FOR THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS
#89Tumor cell vaccines
#90ADMINISTRATION OF STING AGONIST AND CHECKPOINT INHIBITORS
#91REDUCTION OF APPLICATION-RELATED SIDE REACTION OF A THERAPEUTIC ANTIBODY
#92METHOD OF TREATING CANCER BY ADMINISTERING AN EPIGALLOCATECHIN GALLATE COMBINED WITH TYROSINE KINASE INHIBITOR
#93A NOVEL HUMAN-MATERIAL-BASED PLATFOM TECHNOLOGY FOR TISSUE ENGINEERING
#94Oral compositions and methods for animals
#95LANTIBIOTICS AND LANTIBIOTIC-PRODUCING BACTERIA
#96DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS
#97TARGETED DISRUPTION OF THE MHC CELL RECEPTOR
#98NOVEL COMPOSITIONS FOR TREATING COLITIS AND/OR PREVENTING COLON CANCER
#99UNIVERSAL BLOOD PRODUCT AND METHODS OF PREPARING AND USING SAME
#100Method for treating cancerous and pre-cancerous skin
#101UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
#102PLECTIN-1 BINDING ANTIBODIES AND USES THEREOF
#103COMPOSITIONS INCLUDING DIFFERENT TYPES OF TRANSFER FACTOR
#104COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#105COLONY FORMING MEDIUM AND USE THEREOF
#106Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
#107Method of administration and treatment
#108Strain of caucasus yoghurt MSR101 and use thereof
#109Activated stem cells and systemic treatment methods for infected wounds
#110Method of administration and treatment
#111TRANSDERMAL PATCHES FOR USE IN AURICULOTHERAPY
#112Method of administration and treatment
#113Method of administration and treatment
#114METHOD OF ADMINISTRATION AND TREATMENT
#115METHOD OF ADMINISTRATION AND TREATMENT
#116Method for treating cancerous and pre-cancerous skin
#117Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#118Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
#119FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES
#120Neuron activator
#121Mutant Bordetella Strains and Methods of Use
#122FOLLICULAR FLUID
#123TRANSFORMING GROWTH FACTOR-BETA-RESPONSIVE POLYPEPTIDES AND THEIR METHODS FOR USE
#124FLT3 DIRECTED CAR CELLS FOR IMMUNOTHERAPY
#125High speed 3D printing system for wound and tissue replacement
#126Synthetic composition for microbiota modulation
#127TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN
#128METHOD OF ADMINISTRATION AND TREATMENT
#129TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#130Method of administration and treatment
#131Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
#132Composition and method for orally administering one or more active agents to a pet
#133ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION
#134TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#135HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF
#136strain ST4 and its efficacies of anti-inflammation and cancer prevention
#137Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and a PARP inhibitor
#138Compositions and methods for wound treatment
#139Compounds and method of preventing or treating cancer using the same
#140TETRAVALENT TLR9 BISPECIFIC ANTIBODY
#141HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLIFERATION
#142Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
#143Method of administration and treatment
#144Echovirus for treatment of tumors
#145Mutant strains and methods of use
#146Protein-based T-cell receptor knockdown
#147METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
#148METHODS OF AVOIDING EXCIPIENT-BASED ADVERSE EFFECTS AND OF EXPLOITING BIOLOGICAL PROPERTIES OF GRAS COMPOUNDS
#149REDUCTION OF APPLICATION-RELATED SIDE REACTION OF A THERAPEUTIC ANTIBODY
#150Composition for inducing proliferation or accumulation of regulatory T cells
#151Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors
#152TREATMENT OF PTSD
#153Isotope enhanced ambroxol for long lasting autophagy induction
#154Anti-OX40 antibodies and uses thereof
#155Quinazolines compound, preparation method therefor and application thereof
#156METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
#157DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN
#158TREATMENT OF CYTOKINE RELEASE SYNDROME BY DECREASING LEVEL OF PROINFLAMMATORY CYTOKINE
#159CELL
#160Methods for inducing cell division of postmitotic cells
#161METHODS AND COMPOSITIONS OF INCORPORATING A BIOACTIVE AGENT AND USE THEREOF
#162CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO AVB6 INTEGRIN AND METHODS OF USE THEREOF TO TREAT CANCER
#163Engineered Antibody Compounds and Conjuates Thereof
#164Nucleoporins as drug targets for anti-proliferative therapeutics
#165DIET THERAPY OF INTRACTABLE CANCER AND MEDICAL DIET SUITABLE THEREFOR
#166Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy
#167Composition and method for promoting reduction of heat stress in animals
#168BCMA binding molecules and methods of use thereof
#169MICROPARTICLES, METHODS FOR THEIR PREPARATION AND USE
#170Targeted disruption of the MHC cell receptor
#171Compositions including different types of transfer factor
#172Antigen binding molecules and methods of use thereof
#173Method of administration and treatment
#174Recombinant AAV variants and uses thereof
#175Methods of transfection for large cargo using poly(beta-amino esters)
#176Method of administration and treatment
#177Nucleic acids comprising polynucleotides encoding chimeric antigen receptors
#178Composition and method for orally administering one or more active agents to a pet
#179Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
#180Lipid particle composition and pharmaceutical composition
#181Oral compositions and methods for animals
#182Generation of human oocytes
#183METHODS OF DETERMINING DOSING OF A THERAPEUTIC AGENT BASED ON MEASURED LEVELS OF A METABOLITE
#184Composition for inducing proliferation or accumulation of regulatory T cells
#185Composition for inducing proliferation or accumulation of regulatory T cells
#186FGFR4 inhibitor, preparation method therefor, and applications thereof
#187Isotope enhanced ambroxol for long lasting autophagy induction
#188System and method for electric pulse based activation of biological samples
#189Therapeutic cancer vaccine
#190Antibodies binding to HLA-A2/WT1
#191Antibody to programmed cell death 1 (PD-1) and use thereof
#192Combinatory treatment strategies of cancer based on RNA polymerase I inhibition
#193Compositions and methods for reducing adiposity by inhibiting FSH/FSHR
#194Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
#195Sperm activator and uses thereof
#196Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
#197COMPOSITIONS AND METHODS FOR TARGETING FRUCTOSE ENZYMES AND TRANSPORTERS FOR THE TREATMENT OF CANCER
#198Oxygen reduction disposable kits, devices and methods of use thereof
#199Nonviral minicircle vector carrying SOX gene and construction method therefor
#200T cell compositions
#201Modified dystrophin proteins
#202Compositions and methods for reducing tumor cell growth at a site of solid tumor excision
#203Pharmaceutical composition and methods for the prevention and/or treatment of using artificial bacterial colonization
#204Chimeric antigen receptor (CAR) comprising a CD19-binding domain
#205Dermatologic composition containing and
#206Integrated mixotrophic fermentation method
#207Folding biological tissue via programmed cellular contractility
#208Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
#209DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN
#210Plectin-1 binding antibodies and uses thereof
#211Compositions and methods for wound treatment
#212Neuron activator
#213METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#214METHOD OF ADMINISTRATION AND TREATMENT
#215Colony forming medium and use thereof
#216Toxin and method for preparing intermediate thereof
#217Isolation of extracellular vesicles (EVs) from red blood cells for gene therapy
#218Composition for inducing proliferation or accumulation of regulatory T cells
#219Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
#220Synthetic composition for microbiota modulation
#221extract as an immunogenic agent
#222Composition for inducing proliferation or accumulation of regulatory T cells
#223Mutated von Willebrand factor
#224Method of determining cellular protein homeostasis
#225Mutated truncated von Willebrand Factor
#226SDC-2 exosome compositions and methods of isolation and use
#227CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF
#228Chimeric antigen receptor (CAR) comprising a CD22-binding domain
#229Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
#230Purine compounds possessing anticancer activity
#231Activated stem cells and systemic treatment methods for infected wounds
#232CYTOTOXIC BENZODIAZEPINE DERIVATIVES AND CONJUGATES THEREOF
#233REDUCTION OF APPLICATION-RELATED SIDE REACTION OF A THERAPEUTIC ANTIBODY
#234Oxygen reduction disposable kits, devices and methods of use thereof (ORDKit)
#235Antimicrobial compositions for
#236Transforming growth factor-beta-responsive polypeptides and their methods for use
#237Modified Tamm-Horsfall protein and related compositions and methods of use
#238MODULAR SINGLE-USE KITS AND METHODS FOR PREPARATION OF BIOLOGICAL MATERIAL
#239Toxicity management for anti-tumor activity of CARs
#240Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
#241Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
#242Mesothelin-targeted chimeric antigen receptors and methods of making them
#243Production of activated TDP-deoxysugars in recombinant microorganisms
#244Toxicity management for anti-tumor activity of CARs
#245Methods and compositions for cells expressing a chimeric intracellular signaling molecule
#246Methods and compositions for producing pancreatic beta cells
#247Three-dimensional vascular network assembly from induced pluripotent stem cells
#248CANCER THERAPY USING JAK INHIBITOR IN COMBINATION WITH MAPK INHIBITORS
#249Microparticles, methods for their preparation and use
#250Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#251METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET
#252Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
#253Antibodies binding to BMP4, and uses thereof
#254Composition for inducing proliferation or accumulation of regulatory T cells
#255Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
#256SYNTHESIS OF OMEGA FUNCTIONALIZED PRODUCTS
#257COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS
#258FLT3 directed car cells for immunotherapy
#259Methods for inducing cell division of postmitotic cells
#260Compositions and Methods for Treating Chronic Fatigue Syndrome and Related Disorders
#261Combination immune therapy and cytokine control therapy for cancer treatment
#262Method for inducing cerebral cortex neurons
#263Protein-based T-cell receptor knockdown
#264Universal immune cells for cancer immunotherapy
#265METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
#266Universal blood product and methods of preparing and using same
#267Chimeric antigen receptors, encoding nucleic acids and methods of use thereof
#268COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS
#269Recombinant AAV variants and uses thereof
#270COMPOSITION AND METHOD FOR PROMOTING REDUCTION OF HEAT STRESS IN ANIMALS
#271High speed 3D printing system for wound and tissue replacement
#272Antigen binding molecules and methods of use thereof
#273Pathogen-inactivated red blood cell compositions
#274Tablets comprising GLP-1 agonist and enteric coating
#275T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor
#276Polymeric Nanoparticle
#277Compositions and methods for treating mesothelioma post-surgery
#278TECHNIQUE FOR FORMATION AND ASSEMBLY OF 3D CELLULAR STRUCTURES
#279Cell
#280strain with probiotic activity
#281Use of a particular extract of propolis for combating the side effects of chemotherapy
#282TETRAVALENT TLR9 BISPECIFIC ANTIBODY
#283MUSCULAR DYSTROPHY THERAPEUTIC AGENT CONTAINING PLURIPOTENT STEM CELLS DERIVED FROM DENTAL PULP
#284Method of preparing autologous cells and methods of use for therapy
#285Modifying bacteriophage
#286MODIFYING BACTERIOPHAGE USING BETA-GALACTOSIDASE AS A SELECTABLE MARKER
#287Method for proliferating neural progenitor cells and composition for treating neurological diseases containing proliferated neural progenitor cells
#288Bone matrix compositions and methods
#289Mutant strains and methods of use
#290BCMA binding molecules and methods of use thereof
#291ANITMICROBIAL PEPTIDE PRODUCED BY INTESTINAL LACTOBACILLUS SALIVARIUS
#292System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
#293Modified hyaluronic acid polymer compositions and related methods
#294ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
#295Method for producing mycosporine-like amino acid using microbes
#296Oxygen reduction disposable kits, devices and methods of use thereof
#297Targeted disruption of the MHC cell receptor
#298Method and composition for inducing human pluripotent stem cells
#299Mesothelin-targeted chimeric antigen receptors and uses thereof
#300Methods and compositions for mitochondrial replacement therapy